Diana Schmerler

Title: **Innovative Contributions of Diana Schmerler to Sepsis Diagnosis**

Introduction

Diana Schmerler is an accomplished inventor based in Jena, Germany. She holds a significant patent that contributes to the field of medicine, particularly in the diagnosis and management of sepsis and systemic inflammatory response syndrome. Her work plays a crucial role in advancing healthcare and improving patient outcomes.

Latest Patents

Diana Schmerler's notable patent focuses on a method for diagnosing, predicting, and risk stratifying mortality and disease outcomes in patients suspected of having sepsis. This invention involves the determination of antitrypsin (ATT) and transthyretin (TTR) levels, which are correlated with mortality risk. Specifically, a low level of ATT or TTR, or abnormal levels of their fragments, serve as indicators of increased mortality risk and poor disease outcomes.

Career Highlights

Diana Schmerler currently works at Universitätsklinikum Jena, where her innovative research and dedication contribute to significant advancements in the medical field. Her patent is a testament to her commitment to improving diagnostic techniques and patient care.

Collaborations

Throughout her career, Diana has collaborated with notable colleagues such as Michael Kiehntopf and Thomas Deufel. These partnerships have undoubtedly enriched her research and contributed to the successful development of impactful diagnostic methods.

Conclusion

Diana Schmerler exemplifies the role of inventors in the healthcare sector. Her patent addressing sepsis diagnosis demonstrates her dedication to innovation and the betterment of health outcomes. As she continues her work at Universitätsklinikum Jena, the contributions of her research will undoubtedly pave the way for future advancements in medical diagnosis and treatment.